ABBV Abbvie Inc
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
$150.00 -0.57 (-0.38%)
As of 05/27/2022 16:03:14 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Large cap
GICS sector: Health Care
Industry: Drug Manufacturers—General
Index country: USA
Country of incorporation: USA
IPO date: 12/10/2012
Outstanding shares: 1,767,110,083
Average volume: 6,557,040
Market cap: $266,073,765,197
Current dividend yield: 3.55%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: B92SR70
Valuation (See tab for details)
PE ratio: 21.24
PB ratio: 16.28
PS ratio: 4.69
Return on equity: 76.64%
Net income %: 22.00%